Video Latest - ecancer

Updated results on phase III CLL trial shows 90% response rate using ibrutinib

Dr Claire Dearden - Royal Marsden Hospital, London, UK

29 Apr 2015

Latest trials and outcomes with new CLL treatments

Dr George Follows and Professor Peter Hillmen

29 Apr 2015

Developing treatments for indolent non hodgkin lymphoma

Dr Andrew Davies and Dr Paul Fields

29 Apr 2015

Cancer Core Europe: Vall d'Hebron Institute of Oncology

Prof Alejandro Piris - Vall d'Hebron Institute of Oncology, Barcelona, Spain

20 Oct 2014

Cancer Core Europe: Cancer Research UK Cambridge Institute

Prof Carlos Caldas - Cancer Research UK Cambridge Institute, Cambridge, UK

20 Oct 2014

Cancer Core Europe: Karolinska Institute

Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden

20 Oct 2014

Cancer Core Europe: Institut Gustave Roussy

Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France

20 Oct 2014

Cancer Core Europe: Netherlands Cancer Institute

Prof Jan Schellens - Netherlands Cancer Institute, Amsterdam, Netherlands

20 Oct 2014

Cancer Core Europe: Questions and answers

Prof Lex Eggermont, Prof Carlos Caldas, Prof Ulrik Ringborg, Prof Jan Schellens, Prof Piris, Prof Lenz

20 Oct 2014

TAT 2015: Biological underpinnings of targeted therapies and the importance of dialogue and collaboration

Prof Lee Ellis - MD Anderson Cancer Centre, Texas, USA

14 Oct 2014

TAT 2015: Cutting edge research and unique interaction between academia and industry

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France

14 Oct 2014

Biomarker found to aid in screening of squamous cell carcinoma

Dr Khadija Aljefri - Royal Victorian Infirmary Newcastle, Newcastle, UK

11 Sep 2014

Video